<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Zhang B</submitter><funding>NCATS NIH HHS</funding><funding>NHLBI NIH HHS</funding><pubmed_abstract>&lt;h4>Importance&lt;/h4>Post-acute sequelae of SARS-CoV-2 infection (PASC) remains a major public health challenge. While previous studies have focused on characterizing PASC and identifying its subphenotypes in children and adolescents following an initial SARS-CoV-2 infection, the risks of PASC with Omicron-variant reinfections remain unclear. Using a real-world data approach, this study investigates the risks of PASC following reinfections during the Omicron phase in the pediatric population.&lt;h4>Objective&lt;/h4&gt;To investigate the risks of PASC diagnosis and 24 PASC symptoms and conditions after reinfection of SARS-CoV-2 during Omicron period in the pediatric population.&lt;h4>Design setting and participants&lt;/h4>This retrospective cohort study used data from the RECOVER consortium comprising 40 ch</pubmed_abstract><journal>medRxiv : the preprint server for health sciences</journal><pagination>2025.03.28.25324858</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11974971</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Reinfection with SARS-CoV-2 in the Omicron Era is Associated with Increased Risk of Post-Acute Sequelae of SARS-CoV-2 Infection: A RECOVER-EHR Cohort Study.</pubmed_title><pmcid>PMC11974971</pmcid><funding_grant_id>OT2 HL161847</funding_grant_id><funding_grant_id>UL1 TR001878</funding_grant_id><pubmed_authors>Horowitz CR</pubmed_authors><pubmed_authors>Jhaveri R</pubmed_authors><pubmed_authors>Chuang CH</pubmed_authors><pubmed_authors>Liebovitz DM</pubmed_authors><pubmed_authors>Bisyuk Y</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Wu Q</pubmed_authors><pubmed_authors>Taylor BW</pubmed_authors><pubmed_authors>Zhou T</pubmed_authors><pubmed_authors>Fort D</pubmed_authors><pubmed_authors>Cowell LG</pubmed_authors><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Williams DA</pubmed_authors><pubmed_authors>Forrest CB</pubmed_authors><pubmed_authors>Suresh S</pubmed_authors><pubmed_authors>Schwenk HT</pubmed_authors><pubmed_authors>Chrischilles EA</pubmed_authors><pubmed_authors>Mosa ASM</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Becich MJ</pubmed_authors><pubmed_authors>Ladino N</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Blancero F</pubmed_authors><pubmed_authors>Morris JS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reinfection with SARS-CoV-2 in the Omicron Era is Associated with Increased Risk of Post-Acute Sequelae of SARS-CoV-2 Infection: A RECOVER-EHR Cohort Study.</name><description>&lt;h4>Importance&lt;/h4>Post-acute sequelae of SARS-CoV-2 infection (PASC) remains a major public health challenge. While previous studies have focused on characterizing PASC and identifying its subphenotypes in children and adolescents following an initial SARS-CoV-2 infection, the risks of PASC with Omicron-variant reinfections remain unclear. Using a real-world data approach, this study investigates the risks of PASC following reinfections during the Omicron phase in the pediatric population.&lt;h4>Objective&lt;/h4&gt;To investigate the risks of PASC diagnosis and 24 PASC symptoms and conditions after reinfection of SARS-CoV-2 during Omicron period in the pediatric population.&lt;h4>Design setting and participants&lt;/h4>This retrospective cohort study used data from the RECOVER consortium comprising 40 ch</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-06T03:24:39.729Z</modification><creation>2025-07-06T03:04:15.566Z</creation></dates><accession>S-EPMC11974971</accession><cross_references><pubmed>40196285</pubmed><doi>10.1101/2025.03.28.25324858</doi></cross_references></HashMap>